Pfizer Q2 net dips 12 percent at Rs 111.15 crore
New Delhi: Drug firm Pfizer reported a 12 percent dip in standalone net profit to Rs 111.15 crore for the quarter ended September 30, 2017.
The company had posted a net profit of Rs 126.33 crore for the corresponding period of the previous fiscal, Pfizer said in a filing to BSE.
Standalone revenue from operations rose to Rs 571.11 crore as against Rs 557.66 crore for the same period year ago.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd